PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

Ozempic and Wegovy Side Effects Linked To BLINDNESS?

Clinician6:06Jul 2024

Today’s cheapest semaglutide$39/mo at Wellmedr, sale price.Compare all semaglutide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this video, the channel responds to news coverage asking whether Ozempic and Wegovy cause blindness. He says new research shows a stronger association between these semaglutide medications and nonarteritic anterior ischemic optic neuropathy (NAION), a type of eye stroke that can cause permanent vision loss. He explains that Ozempic is prescribed for type 2 diabetes and often used off label for weight loss, while Wegovy is the repackaged, differently dosed version approved for weight loss. According to the study he cites, people with diabetes who took these medications were four times more likely to develop NAION, and people with obesity were over seven times more likely.

Published by Dr. EyeGuy on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

He describes NAION as reduced blood flow to the optic nerve that causes painless, sudden vision loss, often noticed on waking as a dimmed or blurry lower half of vision in one eye. He says it is rarely seen in both eyes, can affect walking, steps and driving, and has no treatment, so lost vision likely will not return. He stresses two points: the researchers are not claiming the drugs cause NAION, and many people taking them already have higher-risk conditions such as obesity, diabetes and high blood pressure.

He then covers two other ways these medications can change vision, both tied to a sharp drop in blood sugar. First, diabetic retinopathy can appear or worsen at first, though he says this also happens with other type 2 diabetes medications and that long-term research points to better eye and overall health. He advises working closely with an eye doctor and primary care doctor. Second, the lens inside the eye can change thickness, causing blur and a prescription change that he says can take 3 to 4 months to stabilize, sometimes requiring new glasses.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The video says new research shows a stronger association between Ozempic or Wegovy and NAION, an eye stroke that can cause permanent blindness.
  2. 1:04 According to the study he cites, people with diabetes were four times more likely and people with obesity over seven times more likely to develop NAION.
  3. 1:38 He explains that NAION usually causes painless vision loss in one eye, often the lower half, and has no treatment.
  4. 2:44 He notes the study does not claim the drugs cause NAION, and that many users already have higher-risk conditions such as obesity, diabetes and high blood pressure.
  5. 3:07 He says a rapid blood sugar drop can cause diabetic retinopathy to appear or worsen at first, and advises close monitoring with eye and primary care doctors.
  6. 4:52 He says blood sugar changes can alter lens thickness, causing blur and a prescription change that may take 3 to 4 months to stabilize.

Key moments

Tap one to play from there.

  1. 1:04 Dose change
  2. 2:30 Exercise and strength
  3. 4:22 How it works

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, Wegovy and semaglutide

Questions this video answers

Do Ozempic and Wegovy cause blindness?

The channel says the study does not claim the drugs cause NAION or blindness. It shows a stronger association between these medications and the eye condition, and he notes many people taking them already have higher-risk conditions.

What is NAION and what are its symptoms?

He describes NAION as an eye stroke in which blood flow to the optic nerve is restricted. It causes painless, sudden vision loss, often the bottom half of vision in one eye, and he says there is no treatment and the loss is likely permanent.

How much higher is the risk of NAION with Ozempic or Wegovy?

According to the study he describes, people with diabetes who took these medications were four times more likely to develop NAION, and people with obesity were over seven times more likely.

Can semaglutide change my vision in other ways?

He says a sudden drop in blood sugar can cause diabetic retinopathy to appear or worsen at first, and can change the thickness of the lens in the eye. He says the lens change can take 3 to 4 months to stabilize, sometimes needing new glasses.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

  • Ozempic for weight loss, and where the ladder runs out

    Ozempic is approved for type 2 diabetes, not for weight loss. Taking it to lose weight is off-label, which is legal, extremely common, and a prescriber's decision. The consequence nobody mentions is the ceiling: Ozempic's doses stop at 2 mg while Wegovy, the same molecule approved for weight, goes to 2.4 mg with a 7.2 mg strength above that. Someone using Ozempic for weight eventually runs out of ladder, and switching brand is the usual answer.

  • Wegovy vs Ozempic: the same drug, and why the box still decides what you pay

    Wegovy and Ozempic are both semaglutide from Novo Nordisk. The difference is the label: Ozempic is approved for type 2 diabetes and tops out at 2 mg a week; Wegovy is approved for weight loss and goes to 2.4 mg, or 7.2 mg in the HD pen. Both now come as a daily pill as well. The label decides whether a plan pays and what cash costs: direct from Novo, both pens are $349 a month up to 1 mg, and Ozempic 2 mg is $499.

Next steps

Ozempic prices

Insurance

Find more like it

Side effectsDose changeHow it works

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV